Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Pancreatic Neoplasms × ponatinib × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Neoplasms 6 Leukemia 5 Neoplasms by Histologic Type 4 Myeloproliferative Disorders 4 Leukemia, Myeloid 4 Hematologic Diseases 4 Bone Marrow Diseases 4 Carcinoma, Non-Small-Cell Lung 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoproliferative Disorders 2 Lymphatic Diseases 2 Leukemia, Myeloid, Chronic-Phase 2 Immunoproliferative Disorders 2 Immune System Diseases 2 Thyroid Neoplasms 1 Small Cell Lung Carcinoma 1 Piebaldism 1 Malignant Hepatobiliary Neoplasm 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Head and Neck Neoplasms 1 Glioblastoma 1 Gastrointestinal Stromal Tumors 1 Gastrointestinal Neoplasms 1 Carcinoma, Squamous Cell 1 Blast Crisis 1 Adenocarcinoma of Lung 1

Interventions

Gemcitabine 141 Fluorouracil 41 Capecitabine 39 130-nm albumin-bound paclitaxel 39 Oxaliplatin 37 Albumin-Bound Paclitaxel 35 Leucovorin 31 Erlotinib Hydrochloride 29 Radiotherapy 20 Irinotecan 20 Bevacizumab 19 pembrolizumab 18 Radiosurgery 16 Docetaxel 16 Cyclophosphamide 15 Taxes 11 Cisplatin 11 Cetuximab 11 folfirinox 9 Nivolumab 9 Ipilimumab 7 Standard of Care 6 Radiation 6 spartalizumab 5 durvalumab 5 dehydroftorafur 5 Surgical Procedures, Operative 5 Paclitaxel 5 Hydroxychloroquine 5 Ascorbic Acid 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡